Are your patients with metastatic castrate-resistant
prostate cancer eligible for a Phase III clinical trial?
Now enrolling patients with metastatic
castrate-resistant prostate cancer
Learn more about a Phase III clinical
trial in prostate cancer
© 2017 Genentech USA, Inc. All rights reserved. BIO/062717/0106